Baker / Tisch Capital (GP), LLC Insider Trading $GEVA SYNAGEVA BIOPHARMA CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Baker / Tisch Capital (GP), LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Baker / Tisch Capital (GP), LLC. Baker / Tisch Capital (GP), LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX).

Baker / Tisch Capital (GP), LLC in SYNAGEVA BIOPHARMA CORP

Trading Symbol: GEVA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker / Tisch Capital (GP), LLC: Director
Holdings: 160,420 shares
Latest Transaction: Oct 04 2006

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Baker / Tisch Capital (GP), LLC in SYNAGEVA BIOPHARMA CORP

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADLR, ALTH, IBPI, BCRX, GHDX, INCY, NRGN, SGEN, GEVA, VPHM

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 04 2006GEVASYNAGEVA BIOPHARMA ...Baker / Tisch Capital (GP), LL ...DirectorSellJ0.00126,4150160,420286.8 K to 160.4 K (-44.07 %)

Page:   1